glycerol has been researched along with exenatide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, S; Han, B; Lu, Y; Sui, C; Weng, P; Wu, H; Xia, F; Xu, H; Zhai, H; Zhang, H | 1 |
| Haag, R; Kutifa, D; Licha, K; Schirner, M; Tully, M; Wedepohl, S; Weise, C | 1 |
2 other study(ies) available for glycerol and exenatide
| Article | Year |
|---|---|
The GLP-1 analogue exenatide improves hepatic and muscle insulin sensitivity in diabetic rats: tracer studies in the basal state and during hyperinsulinemic-euglycemic clamp.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Exenatide; Fasting; Glucagon-Like Peptide-1 Receptor; Gluconeogenesis; Glucose Clamp Technique; Glycerol; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Liver; Male; Muscle, Skeletal; Peptides; Rats, Sprague-Dawley; Receptors, Glucagon; Streptozocin; Venoms | 2014 |
Prolonged activity of exenatide: Detailed comparison of Site-specific linear polyglycerol- and poly(ethylene glycol)-conjugates.
Topics: Animals; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Exenatide; Glycerol; Half-Life; Hypoglycemic Agents; Male; Mice; Peptides; Polyethylene Glycols; Polymers | 2021 |